Open AccessCOVID-19 vaccine trial ethics once we have efficacious vaccines
Author(s) -
David Wendler,
Jorge Flores Ochoa,
Joseph Millum,
Christine Grady,
Holly A. Taylor
Publication year - 2020
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abf5084
Subject(s) - covid-19 , medicine , placebo , clinical trial , virology , vaccine trial , intensive care medicine , alternative medicine , vaccination , pathology , infectious disease (medical specialty) , outbreak , disease
Some placebo-controlled trials can continue ethically after a candidate vaccine is found to be safe and efficacious
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom